// App-Quantinova.ai

4114 : Blocking Ezrin can inhibit HGF/Met signaling-induced metastasis

Researchers

Presenter

  • Yanlin Yu

Principal Investigators

  • Liping Huang

  • Glenn Merlino

Medical Centers

  • NCI-CCR, Bethesda, MD.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

  • Solid malignancies

Biomarkers

  • Mitogen-activated protein kinase

  • Hepatocyte growth factor

  • Hepatocyte growth factor receptor

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved